Silverfin false false 30/11/2024 06/12/2023 30/11/2024 D Mack 06/12/2023 J Mack 06/12/2023 05 August 2025 no description of principal activity 15333333 2024-11-30 15333333 bus:Director1 2024-11-30 15333333 bus:Director2 2024-11-30 15333333 core:CurrentFinancialInstruments 2024-11-30 15333333 core:ShareCapital 2024-11-30 15333333 core:RetainedEarningsAccumulatedLosses 2024-11-30 15333333 core:AdditionsToInvestments 2024-11-30 15333333 core:CostValuation 2024-11-30 15333333 core:CostValuation 2023-12-05 15333333 core:SubsidiariesWithMaterialNon-controllingInterests core:CurrentFinancialInstruments 2024-11-30 15333333 2023-12-06 2024-11-30 15333333 bus:FilletedAccounts 2023-12-06 2024-11-30 15333333 bus:SmallEntities 2023-12-06 2024-11-30 15333333 bus:AuditExemptWithAccountantsReport 2023-12-06 2024-11-30 15333333 bus:PrivateLimitedCompanyLtd 2023-12-06 2024-11-30 15333333 bus:Director1 2023-12-06 2024-11-30 15333333 bus:Director2 2023-12-06 2024-11-30 iso4217:GBP xbrli:pure

Company No: 15333333 (England and Wales)

GENATEC GROUP LIMITED

Unaudited Financial Statements
For the financial period from 06 December 2023 to 30 November 2024
Pages for filing with the registrar

GENATEC GROUP LIMITED

Unaudited Financial Statements

For the financial period from 06 December 2023 to 30 November 2024

Contents

GENATEC GROUP LIMITED

BALANCE SHEET

As at 30 November 2024
GENATEC GROUP LIMITED

BALANCE SHEET (continued)

As at 30 November 2024
Note 30.11.2024
£
Fixed assets
Investments 3 111,900
111,900
Current assets
Debtors 4 1,224,951
Cash at bank and in hand 139
1,225,090
Creditors: amounts falling due within one year 5 ( 80,202)
Net current assets 1,144,888
Total assets less current liabilities 1,256,788
Net assets 1,256,788
Capital and reserves
Called-up share capital 1,000
Profit and loss account 1,255,788
Total shareholders' funds 1,256,788

For the financial period ending 30 November 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Genatec Group Limited (registered number: 15333333) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

D Mack
Director
J Mack
Director

05 August 2025

GENATEC GROUP LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 06 December 2023 to 30 November 2024
GENATEC GROUP LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 06 December 2023 to 30 November 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Genatec Group Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Hill Farm Rectory Road, Lower Bodham, Holt, NR25 6PR, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the Company as an individual entity and not about its group.

Dividend income

Dividend income from investments is recognised when the shareholders' rights to receive payment have been established (provided that it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably).

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

2. Employees

Period from
06.12.2023 to
30.11.2024
Number
Monthly average number of persons employed by the Company during the period, including directors 0

The Company has no employees other than the Directors, who did not receive any remuneration.

3. Fixed asset investments

30.11.2024
£
Subsidiary undertakings 2,000
Other investments and loans 109,900
111,900

Investments in subsidiaries

30.11.2024
£
Cost
At 06 December 2023 0
Additions 2,000
At 30 November 2024 2,000
Carrying value at 30 November 2024 2,000

Other investments Total
£ £
Cost or valuation before impairment
At 06 December 2023 0 0
Additions 109,900 109,900
At 30 November 2024 109,900 109,900
Carrying value at 30 November 2024 109,900 109,900

4. Debtors

30.11.2024
£
Amounts owed by own subsidiaries 1,092,562
Prepayments and accrued income 132,389
1,224,951

5. Creditors: amounts falling due within one year

30.11.2024
£
Amounts owed to directors 8,202
Accruals 2,000
Other creditors 70,000
80,202

6. Related party transactions

Transactions with the entity's directors

30.11.2024
£
Balance owed to Directors 8,202

The above balance was owed to the Directors of the company at the year end, no interest is charged on this balance and the amount is deemed repayable on demand.

Other related party transactions

The company has taken advantage of the exemption under 33.1A, allowing wholly owned group members to depart from the requirements to disclose transactions with other group companies.